 Home > Popular Keywords > Keyword List P > phillips 66 stock price

phillips 66 stock price

Free access to latest phillips 66 stock price news. Echemi provides a lot of different insights into phillips 66 stock price.

Qianyuan Pharmaceutical: There is no case of using voluntary information disclosure to cater to market hot spots to speculate on the stock price

 Time of Update: 2022-05-28

Its subsidiary Jiayi Pharmaceutical and Laos pharmaceutical company Laos Alliance Pharmaceutical Group Co.
The insulin giant's stock price has been falling all the way!

 Time of Update: 2022-05-07

Among them, Insulin Glargine Injection (Chang Xiulin) is the flagship product of Gan & Lee Pharmaceuticals, whose sales revenue accounts for more than 90% of the total revenue every year, and the product structure is single .
The stock price and market value have doubled within two months, and this pharmaceutical company has been investigated by institutions.

 Time of Update: 2022-05-04

the field of water preparations, and the products on sale are doxycycline tablets and argatroban injection; in 2019 and 2021, they successfully issued convertible bonds, Issue stocks to specific objects to raise funds for the construction of industrial
The stock of cumin is not large, and the price has an upward trend!

 Time of Update: 2022-04-27

According to a cumin dealer in Yumen, Gansu, driven by demand, the supply of goods has been moving smoothly recently, and the market is higher than the previous period .
Phillips 66 completes acquisition of PSXP

 Time of Update: 2022-04-25

The merger gave Phillips 66 all limited partnership interests in PSXP that did not belong to Phillips 66 and its affiliates .
Dongfang Shenghong Refining and Chemical Integration Project officially signed a 41.5 billion loan, and the stock price hit a five-year high

 Time of Update: 2022-03-21

Oriental Shenghong once announced on August 13 that Shenghong Refinery and the above-mentioned syndicate had signed a syndicated closing agreement, confirming a loan share of 41.
Stock price dives, R&D burns money, biopharmaceutical companies move forward tenaciously in 2021

 Time of Update: 2022-03-08

first subcutaneously injected PD-L1 antibody jointly promoted by Corning Jereh, Sidi Pharmaceuticals and Simcere Pharmaceuticals The drug envolizumab injection was approved for marketing, benefiting from an innovative nano-dosage form, which shortens
Ascletis, Junshi, and Genting share prices collectively break out, how far can the new crown oral drug concept stocks go?

 Time of Update: 2022-02-22

New crown oral drug concept stocks are being sought after by the market, and the momentum is far more enthusiastic
70% of the price is reduced for 70% of the purchase volume. Can Changchun Hi-Tech, whose stock

 Time of Update: 2022-02-21

Judging from the volume of reports, whether it is Changchun High-tech or Anke Bio, the impact of Guangdong Alliance's centralized procurement on the performance of growth hormone companies is limited .
Ascletis, Junshi, and Genting share prices collectively break out, how far can the new crown oral drug concept stocks go?

 Time of Update: 2022-02-20

In fact, in recent days, the stock prices of many domestic pharmaceutical companies that have deployed oral new crown drugs have generally shown a continuous upward trend .
The revenue growth rate of Muyuan shares fell in less than a year, and the stock price fell nearly four...

 Time of Update: 2022-02-19

Behind Muyuan's announcement of a sharp drop in net profit is that the breeding industry as a whole was under pressure from a large release of production capacity and a falling price of live pigs during the year .
The Internet medical sector rose, and the stock prices of many companies rose sharply

 Time of Update: 2022-01-25

)", which put forward stricter requirements on the sales model and consultation model of Internet medical platforms, emphasizing that prescriptions should be used before medicines. , The first consultation offline, it is clearly proposed
Conspiracy to manipulate stock prices to make tens of millions of yuan, Jinxin Nongyuan holding shares...

 Time of Update: 2022-01-23

In order to maintain the share price of "Jinxinnong", Wang Jianneng transferred a total of 10 million yuan to the bank account designated by Dou Xiaoyu from August 20, 2018 to September 19, 2018, as a trading margin.
Cinda failed to introduce ISAC drug clinical research and development, Bolt stock price plummeted 56%

 Time of Update: 2021-12-30

As a new immunotherapy, the Boltbody ISAC platform consists of three main components: tumor-targeting antibodies, non-degradable linkers, and proprietary immunostimulants (TLR 7/8 agonists) used to activate the patient’s innate immune system .
After the stock price fell sharply, Muyuan said that all commercial acceptance bills have been...

 Time of Update: 2021-12-27

As of December 6, 2021, the company's 9 subsidiaries have overdue unpaid commercial acceptance bills totaling RMB 7.
National talks closing day: CAR-T corporate representatives did not show up, PD-1 "F4" stock prices fell

 Time of Update: 2021-12-07

It is reported that representatives of Rongchang Biological Enterprise appeared at the negotiation site today, and the company's taltacept and vedicitumumab are the drugs that participated in the medical insurance negotiations for the first time .
When medical insurance negotiations no longer become bad news for the stock market, does it mean

 Time of Update: 2021-12-07

The annual medical insurance negotiations have ended. Although the specific results of the negotiations have not yet been announced, the stock prices of various companies have
First-in-class immune proteasome inhibitor phase II results positive, stock price rose more than 60%

 Time of Update: 2021-12-02

Article source: Medical Rubik's Cube InfoAuthor: Shi BeiOn November 15, Kezar Life Sciences announced the mid-term results of its first-in-class selective immune proteasome inhibitor KZR-616 for the treatment of active, proliferative lupus nephritis (LN) MISSION study phase II trial .
Why did the stock price of the leading company get the orphan drug identification?

 Time of Update: 2021-12-01

Source: Zhongkang FIC Intelligence database Prior to this, Genxi Biosciences has announced the latest clinical research progress of GC012F in the treatment of relapsed/refractory multiple myeloma at a number of top international academic conferences .
Obvious supply and demand gap, chemical products welcome the overall price hike, and related companies benefit (with stock)

 Time of Update: 2021-11-19

>On February 22, relevant business executives of the company told a reporter from China Securities News that “during the Spring Festival, due to cold waves and other factors, the production load of PVC-related equipment in Europe, America, Japan

Related Keywords

phillips stock price phillips conoco stock price phillips oil stock price phillips petroleum stock price

Go to Page

Hot Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

punchout catalog(268)

propranolol extended release(294)

protocatechuic acid(290)

psychomotor agitation(284)

propranolol generic(294)

psu application(277)

provent systems(289)

propylene glycol density(214)

puromycin selection(278)

prothrombin activator(285)

What's trending

Top Keywords

p gp inducers list

perchloric acid 70

p&2

prudential equity group

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

phillips 66 stock price

Related Tags

Related Keywords